Is Extrapolation of the Safety and Efficacy Data in One Indication to Another Appropriate for Biosimilars?

Overview of attention for article published in The AAPS Journal, October 2013

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

policy: 1 policy source

Citations

dimensions_citation: 75 Dimensions

Readers on

mendeley: 103 Mendeley

Summary Policy documents Dimensions citations

So far, Altmetric has seen 1 policy document that references this research output.

Infliximab

Cited by Canadian Agency for Drugs and Technologies in Health on 08 Sep 2015

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.